Senior insider sale
Chief Financial Officer at TREVI THERAPEUTICS, INC. — senior position signals high conviction
$6.7K
2.97K shares
What this filing means
DELFINI LISA plans to sell 2.97K shares of TREVI THERAPEUTICS, INC. valued at approximately $6.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/11/2023ACC: 0001972481-23-000081
Officer· Chief Financial Officer
Since Aug 2021
2.97K
Shares to sell
$6.7K
Approx. market value
4.58K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Options Exercise
Sell to Cover
9/11/2023
4.58KTotal acquired4.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/11/2023 | Options Exercise Sell to Cover | 4.58K | — |
| Total | 4.58K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
682.00
Market value
$1.6K
8/11/2023
—Completed
Units to sell
687.00
Market value
$1.6K
7/11/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.60K
Market value
$3.5K
9/11/2023
Total
Units
2.97K
Value
$6.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/11/2023 | 682.00 | $1.6K | — | Completed |
7/11/2023 | 687.00 | $1.6K | — | Completed |
| Planned — Approximate Date | ||||
9/11/2023 | 1.60K | $3.5K | NASDAQ | Planned |
| Total | 2.97K | $6.7K | ||